https://www.thefocalpoints.com/p/breaking-first-in-man-oral-proteolytic?
BREAKING–First-in-Man Oral Proteolytic and Thrombolytic Dissolution of Intra-Arterial COVID-19 Vaccine Thrombi
Article Excerpt:
In this breaking interview, Dr. Takuji Shirasawa from the Ochanomizu Health and Longevity Clinic describes a 60-year old Japanese man who took 4 Pfizer COVID-19 vaccines and presented with a loss of mental clarity otherwise known as “brain fog.” Shirasawa used MR angiography to demonstrate sessile bilateral arterial thrombi in the carotid bulbs. His hypothesis was that mini-blood clots may be responsible for the neurological and cognitive symptoms.
Shirasawa performed a N-of-1 trial giving the patient a complex blend of oral proteolytic and thrombolytic enzymes featuring nattokinase, bromelain, serrapeptase, and papain adding over a dozen natural ingredients given in proprietary blends from Texas based Phytomedic Labs. The patient was also administered aspirin 100 mg per day. (See link for article & video)
_______________
For more:
- https://madisonarealymesupportgroup.com/2016/04/22/systemic-enzymes/
- https://madisonarealymesupportgroup.com/2019/11/18/link-between-inflammation-mental-sluggishness-shown-how-msm-systemic-enzymes-and-melatonin-can-help/
- https://madisonarealymesupportgroup.com/2018/03/05/how-proteolytic-enzymes-may-help-lyme-msids/
- https://madisonarealymesupportgroup.com/2023/12/08/the-potential-benefits-of-proteolytic-enzymes-to-help-manage-rheumatoid-arthritis/
- https://madisonarealymesupportgroup.com/2023/05/03/79216/ Antiviral effects of Nattokinase
- https://madisonarealymesupportgroup.com/2024/09/20/resolving-persistent-spike-protein-syndrome/
- https://madisonarealymesupportgroup.com/2025/02/04/treatment-recovery-of-mrna-shot-injury/